Arkema has achieved the pre-registration of all its substances concerned by the Reach regulation
According to the company, Arkema has endorsed the objectives of Reach from the very beginning, in the firm belief that a continuous improvement in our knowledge of substances and their safe use provides an opportunity to fulfil the legitimate expectations of society at large in terms of protection of health and the environment, and to boost the public’s confidence in the chemical industry.
In order to carry through this project on time, Arkema has consolidated its teams by recruiting toxicologists and ecotoxicologists, who are working on the next stages of the registration process, the first cut-off date being November 2010, in particular within "consortia" which are being set up to prepare joint registration dossiers involving several producers of the same substance.
Over and above the strictly regulatory issue, Arkema is intent on drawing on its R&D teams’ capacity for innovation to anticipate the progress and changes that will be brought about by the deployment of Reach, by offering products and solutions that meet the challenges of sustainable development.
Other news from the department politics & laws
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.